Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00791180 · ClinicalTrials.gov registry record
Posterior Lateral Fusion (PLF) With Dynesys
A clinical trial, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 38
- Enrollment target
NCT00791180: Completed study, sponsored by Zimmer Biomet.
NCT00791180 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00791180 has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
The primary purpose of this study is to track and document the clinical outcomes of patients with radicular pathology following posterior lateral fusion with the Dynesys Spinal System. Secondary purpose of this study is to assess outcomes with historical controls along a continuum of motion and anatomy sparing procedures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2006-03 |
| Est. Completion | 2011-03 |
What the finished NCT00791180 record still lists
NCT00791180 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00791180 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00791180 about?
NCT00791180 is a clinical study titled "Posterior Lateral Fusion (PLF) With Dynesys". The primary purpose of this study is to track and document the clinical outcomes of patients with radicular pathology following posterior lateral fusion with the Dynesys Spinal System. Secondary purpose of this study is to assess outcomes with historical controls along a continuum of motion and anat...
What is the current status of trial NCT00791180?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2006-03. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT00791180?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia